Immunotherapy News and Research

Latest Immunotherapy News and Research

Study explores new immunotherapy combinations to treat prostate cancer

Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.

29 Mar 2017

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

City of Hope, a world-renowned independent research and cancer and diabetes treatment center, will highlight a variety of basic research and population studies at the annual meeting of the American Association for Cancer Research at the Walter E. Washington Convention Center in Washington, D.C., April 1 to 5.

28 Mar 2017

Neurology researchers on the hunt for biomarker signal for early detection of Alzheimer's disease

Around 100,000 Austrians suffer from Alzheimer's disease and 16,000 from Parkinson's. Experts estimate that, in view of the ageing population, these numbers are set to triple over the next 30 years.

27 Mar 2017

New research suggests need for oral food challenge to properly diagnose additional nut allergies

Many patients with a history of a single tree nut allergy are told to avoid all other tree nuts. But is that necessary? If you have a tree nut allergy and were advised to avoid other tree nuts based only on a positive blood or skin prick test, you may not be allergic to the other nuts.

27 Mar 2017

Combination of high-intensity ultrasound and immunotherapy may be effective in treating cancer

In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer.

25 Mar 2017

Immunotherapy drug becomes first FDA-approved treatment for metastatic MCC

The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.

25 Mar 2017

Study reveals intriguing crosstalk between metabolism and epigenetics in cancer development

A study published in Briefings in Functional Genomics investigated how epigenetics can modulate human's genetic program -- it can emphasize or silence genes.

24 Mar 2017

FARE announces recipients of 2017 Investigator in Food Allergy Awards

Food Allergy Research & Education, the world's largest private source of funding for food allergy research, is pleased to announce the recipients of the 2017 FARE Investigator in Food Allergy Awards after an extraordinarily competitive review process, with more than two dozen researchers submitting high-quality proposals.

22 Mar 2017

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Dana-Farber Cancer Institute and Lifespan leadership are creating a strategic alliance to advance cancer treatment and research.

22 Mar 2017

Brexit impact on science and medicine

It's very difficult to say precisely, but certainly it will have an impact on collaborative work, especially for young companies and academic labs.

21 Mar 2017

Combination approach holds potential for treating lung cancer patients

An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors to more effectively control tumors in the chest with an acceptable risk of severe treatment-related side effects.

17 Mar 2017

LJI researchers unravel molecular underpinnings of exhausted T cells

One reason we survive into adulthood is that cell-killing T cells usually recognize and eliminate cancerous or pathogen-infected cells.

15 Mar 2017

Antibody treats pediatric brain tumors safely and effectively in mice

Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.

15 Mar 2017

Evolution of immuno-oncology

Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).

13 Mar 2017

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.

9 Mar 2017

Research findings show effective way to harness anti-tumor potential of macrophages in cancer therapy

For all the success of a new generation of immunotherapies for cancer, they often leave an entire branch of the immune system's disease-fighting forces untapped.

9 Mar 2017

Researcher explores how military strategy can be used as inspiration for cancer treatment

When David Gisselsson Nord, a cancer researcher at Lund University in Sweden, read a history book last summer, he was struck by the similarities between how cancer and insurgencies evolve over time.

9 Mar 2017

Common cold virus can cause deadly pneumonia in transplant patients, study shows

The common cold is a major source of annoyance for most of us, but new research has found that the most prevalent respiratory infection can be far worse than a stuffy nose for one sector of the population — bone marrow transplant patients.

8 Mar 2017

New biomarker 'Bim' could help predict optimal treatment for metastatic melanoma patients

Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who were previously considered untreatable.

8 Mar 2017

Primary lung cancer tumor may go undiagnosed in some kidney cancer patients

Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C. Simmons Comprehensive Cancer Center's Kidney Cancer Program studied patients with metastatic kidney cancer to the lungs and found that 3.5 percent of the group had a primary lung cancer tumor that had gone undiagnosed. This distinction can affect treatment choices and rates of surviva

7 Mar 2017

Immunotherapy News and Research

Latest Immunotherapy News and Research

Study explores new immunotherapy combinations to treat prostate cancer

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

Neurology researchers on the hunt for biomarker signal for early detection of Alzheimer's disease

New research suggests need for oral food challenge to properly diagnose additional nut allergies

Combination of high-intensity ultrasound and immunotherapy may be effective in treating cancer

Immunotherapy drug becomes first FDA-approved treatment for metastatic MCC

Study reveals intriguing crosstalk between metabolism and epigenetics in cancer development

FARE announces recipients of 2017 Investigator in Food Allergy Awards

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Brexit impact on science and medicine

Combination approach holds potential for treating lung cancer patients

LJI researchers unravel molecular underpinnings of exhausted T cells

Antibody treats pediatric brain tumors safely and effectively in mice

Evolution of immuno-oncology

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Research findings show effective way to harness anti-tumor potential of macrophages in cancer therapy

Researcher explores how military strategy can be used as inspiration for cancer treatment

Common cold virus can cause deadly pneumonia in transplant patients, study shows

New biomarker 'Bim' could help predict optimal treatment for metastatic melanoma patients

Primary lung cancer tumor may go undiagnosed in some kidney cancer patients

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in